Dennis H. Langer has served as a member of our Board of Directors since February 2012. Dr. Langer brings over 25 years of experience in the pharmaceutical, biotechnology, and diagnostics industries in areas that include research & development, global and local marketing, and corporate development. Dr. Langer has served as a director of several public and private specialty pharmaceutical, biotechnology and diagnostic companies, and has been CEO and/or co-founder of several health care companies. From 2005 to 2010, Dr. Langer served as a Managing Partner of Phoenix IP Ventures, a private equity/venture capital firm specializing in life sciences. Previously, he was President, North America, of Dr. Reddy’s Laboratories Limited. From September 1994 until January 2004, Dr. Langer held several high-level positions at GlaxoSmithKline plc, and its predecessor, SmithKline Beecham including, most recently, as a Senior Vice President of Research & Development. Before that, Dr. Langer was President and CEO of Neose Technologies, Inc., and previously held research & development and marketing positions at Eli Lilly, Abbott Laboratories and GD Searle. At the beginning of his career, he was Chief Resident in Psychiatry at Yale University School of Medicine and held clinical fellowships at Harvard Medical School and the National Institutes of Health (NIH). Dr. Langer serves on the Board of Directors of Myriad Genetics, Inc., Dicerna Pharmaceuticals, Inc., and several private companies. Dr. Langer has also served as a Director of Myrexis, Inc., Auxilium Pharmaceutics, Inc., Sirna Therapeutics, Inc., Pharmacopeia, Inc., and Cytogen Corporation. He is a Clinical Professor in the Department of Psychiatry, Georgetown University School of Medicine. Dr. Langer received a J.D. from Harvard Law School, an M.D. from Georgetown University School of Medicine, and a B.A. in Biology from Columbia University.